Membrane Chromatography Market

Advantages offered by novel membrane chromatography techniques is driving the market growth

The market CAGR is being driven by the growing advantages offered by novel membrane chromatography techniques over established ones. Only a very small number of applications, such as the flow-through mode removal of diluted contaminants including viruses, endotoxins, and DNA, call for the employment of membrane chromatography. 

The technique has gained acceptance during the past ten years as the final stage in a number of industrial methods for creating monoclonal antibody therapies. Chromatography is absolutely necessary for downstream processing in the biopharmaceutical sector. It offers significant benefits for applications that do not need for high-resolution separation, such as flow-through process steps, according to the article published in Wiley Online Library in 2016. These benefits include a much cheaper cost in addition to ease of use.

The foundation of chromatography is the idea that when molecules from a mixture are placed to a surface or a solid, they are separated from one another by the stationary fluid phase. To simplify without sacrificing crucial quality traits, the purifying process needs a more powerful separation technology. 

One of the best separation methods is affinity chromatography, which works because of the interactions between the target molecules and the immobilized ligand. It might enable a platform-capable purification strategy that allows for the purification of each molecule using a different affinity media, followed by one or more polishing processes.

The rising trend of manufacturers engaging in joint ventures and the launch of new products in the membrane chromatography market. Membrane chromatography market participants participate in mergers and acquisitions, product launches, and strategic alliances between well-established and up-and-coming firms. 

For instance, the Biopharma division of General Electric Company's Life Sciences division was acquired by Danaher Corporation in 2020, and it was renamed Cytiva once the transaction was finished. Thus, driving the membrane chromatography market revenue.

Emerging markets are playing a pivotal role in the growth of the Global Membrane Chromatography Market Industry. Countries in Asia-Pacific and Latin America are witnessing rapid industrialization and an increase in biopharmaceutical production. This expansion is driving demand for advanced purification technologies, including membrane chromatography. As these regions invest in healthcare infrastructure and biotechnology, the market is expected to flourish. The anticipated growth trajectory suggests that by 2035, the market could reach 0.77 USD Billion, reflecting the increasing adoption of membrane chromatography in these developing economies.

The Global Membrane Chromatography Market Industry is experiencing a surge in demand driven by the biopharmaceutical sector. As the industry continues to expand, the need for efficient purification processes becomes paramount. Membrane chromatography offers a streamlined approach to separating biomolecules, which is essential for the production of therapeutic proteins and monoclonal antibodies. In 2024, the market is valued at 0.14 USD Billion, reflecting the growing reliance on advanced purification technologies. This trend is expected to accelerate as biopharmaceutical sales are projected to reach unprecedented levels, thereby propelling the membrane chromatography market forward.

The Global Membrane Chromatography Market Industry is witnessing a heightened focus on process optimization within various sectors, particularly in pharmaceuticals and biotechnology. Companies are increasingly adopting membrane chromatography due to its ability to enhance yield and reduce processing times. This optimization is crucial as organizations strive to meet regulatory requirements while maintaining product quality. The anticipated compound annual growth rate (CAGR) of 16.78% from 2025 to 2035 underscores the industry's potential for growth, driven by the need for more efficient and cost-effective purification methods.

Environmental sustainability is becoming a critical driver for the Global Membrane Chromatography Market Industry. As industries face increasing pressure to adopt greener practices, membrane chromatography presents a viable solution due to its lower solvent consumption and waste generation compared to traditional methods. This shift towards sustainable practices is not only beneficial for the environment but also aligns with regulatory trends favoring eco-friendly technologies. As organizations prioritize sustainability, the adoption of membrane chromatography is likely to increase, further contributing to market growth and innovation.

Innovations in membrane technology are significantly influencing the Global Membrane Chromatography Market Industry. Recent advancements have led to the development of membranes with enhanced selectivity and permeability, which improve the efficiency of separation processes. These technological enhancements not only reduce operational costs but also increase throughput, making them attractive to manufacturers. As companies invest in research and development, the market is poised for growth, with projections indicating a value of 0.77 USD Billion by 2035. This evolution in membrane technology is likely to attract new players and foster competition within the industry.

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American membrane chromatography market area will dominate this market due to the existence of a well-established biopharmaceutical industry, strong research infrastructure, and supportive government programmes for biopharmaceutical research and development. 

The market expansion is being driven by the early adoption of membrane chromatography technologies in the region, which is home to numerous significant industry participants.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2  MEMBRANE CHROMATOGRAPHY MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe membrane chromatography market accounts for the second-largest market share driven by the increased R&D expenditure by biopharmaceutical companies, rising investment in the R&D industry, and market participants playing a vital role in contributing to the expansion. 

For instance, Sartorius, a renowned  partner of life science research and the biopharmaceutical sector, purchased a subset of Danaher Corporation's life science assets in April 2020. Innovative tools, biosensors, and reagents for protein analysis that are employed in drug discovery will be promoted by the acquisition. Further, the German membrane chromatography market held the largest market share, and the UK membrane chromatography market was the fastest growing market in the European region

The Asia-Pacific Membrane chromatography Market is expected to grow at the fastest CAGR from 2023 to 2032 fueled by rising healthcare infrastructure investments, expanding pharmaceutical industry outsourcing, and expanding biopharmaceutical industry. With the help of domestic and foreign investments, the area has become a significant centre for contract manufacturing and research organisations. 

In addition, a sizable patient population, rising healthcare costs, and encouraging government measures are fostering the development of membrane chromatography in the Asia Pacific region. Moreover, China’s membrane chromatography market held the largest market share, and the Indian membrane chromatography market was the fastest growing market in the Asia-Pacific region.

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the membrane chromatography market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, membrane chromatography industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  membrane chromatography industry to benefit clients and increase the market sector. In recent years, the membrane chromatography industry has offered some of the most significant advantages to market. 

Major players in the membrane chromatography market attempting to increase market demand by investing in research and development operations include Sartorius AG (Germany), Danaher Corporation (US), Merck Millipore (US), Thermo Fisher Scientific (US), 3M (US), Asahi Kasei Corporation (Japan), Cole-Parmer Instrument Company, LLC (US), Restek Corporation (US), Purilogics (US), and GVS Group (Italy).

Danaher Corp creates, produces, and sells industrial, commercial, professional, and medical goods and services. A wide range of testing equipment, communications solutions, water quality systems, sustainable packaging design solutions, medical diagnostic solutions, professional microscopes, life science research tools, product identification solutions, automation solutions, and sensors and controls solutions are all available. 

In Europe, Australia, Asia, and the Americas, the corporation has facilities for manufacturing, sales, distribution, service, and administration. In 2020, the life sciences branch of General Electric Company's Biopharma business was fully acquired by Danaher Corporation and rebranded as Cytiva.

Chemical items are produced and sold by Asahi Kasei Corp. The company's product line consists of acrylonitrile, diagnostic reagents, foam insulation panels, styrene, foundation systems, methyl methacrylate, polystyrene, polyethylene, polymers, functional additives, ion-exchange membranes, membrane filtration systems, medical devices and sensors. 

Additionally, prescription medicines are available. Products from Asahi Kasei are used in industries like electronics, building, healthcare, and chemicals and fibres. It sells these goods under the Duranol, Sepacell, Polydurex, Ceolus, Aciplex, and Hipore names.